Tarsus Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TARSUS, and when can generic versions of TARSUS drugs launch?
TARSUS has one approved drug.
There are six US patents protecting TARSUS drugs.
There are forty patent family members on TARSUS drugs in twenty-five countries and fifteen supplementary protection certificates in fifteen countries.
Drugs and US Patents for Tarsus
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tarsus | XDEMVY | lotilaner | SOLUTION/DROPS;OPHTHALMIC | 217603-001 | Jul 24, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Tarsus | XDEMVY | lotilaner | SOLUTION/DROPS;OPHTHALMIC | 217603-001 | Jul 24, 2023 | RX | Yes | Yes | 11,690,826 | ⤷ Sign Up | ⤷ Sign Up | ||||
Tarsus | XDEMVY | lotilaner | SOLUTION/DROPS;OPHTHALMIC | 217603-001 | Jul 24, 2023 | RX | Yes | Yes | 8,383,659 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
Tarsus | XDEMVY | lotilaner | SOLUTION/DROPS;OPHTHALMIC | 217603-001 | Jul 24, 2023 | RX | Yes | Yes | 11,197,847 | ⤷ Sign Up | ⤷ Sign Up | ||||
Tarsus | XDEMVY | lotilaner | SOLUTION/DROPS;OPHTHALMIC | 217603-001 | Jul 24, 2023 | RX | Yes | Yes | 11,752,137 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Tarsus Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
South Africa | 201103780 | ⤷ Sign Up |
Japan | 2012512838 | ⤷ Sign Up |
Japan | 2024038449 | ⤷ Sign Up |
Brazil | PI0923009 | ⤷ Sign Up |
Colombia | 6341475 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Tarsus Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2379537 | C201730034 | Spain | ⤷ Sign Up | PRODUCT NAME: LOTILANER Y SALES DEL MISMO; NATIONAL AUTHORISATION NUMBER: EU/2/17/206; DATE OF AUTHORISATION: 20170425; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/2/17/206; DATE OF FIRST AUTHORISATION IN EEA: 20170425 |
2379537 | 699 | Finland | ⤷ Sign Up | |
2379537 | 2017C/029 | Belgium | ⤷ Sign Up | PRODUCT NAME: CREDELIO - LOTINALER; AUTHORISATION NUMBER AND DATE: EU/2/17/206 20170427 |
2379537 | 40/2017 | Austria | ⤷ Sign Up | PRODUCT NAME: LOTILANER UND SALZE DAVON; REGISTRATION NO/DATE: EU/2/17/206 (MITTEILUNG) 20170427 |
2379537 | 300891 | Netherlands | ⤷ Sign Up | PRODUCT NAME: LOTILANER EN ZOUTEN DAARVAN; REGISTRATION NO/DATE: EU/2/17/206 20170427 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.